Amiram Katz, a board-certified neurologist, practices at MedAhead Inc. where he sees patients with protracted tick-borne diseases among other neurologically compromised patients. He was recently recognized by Marquis Who’s & Who Top Doctors for dedication, achievements, and leadership in neurology.
Dr. Katz attended the Sackler School of Medicine at Tel Aviv University, where he earned an MD in 1976 with Magna Cum Laude. He went on to complete a residency in Internal Medicine at Sheba Medical Center in 1980, a residency in Neurology at Tel Aviv Medical Center in 1984, a fellowship in medical hypnosis at the University of Haifa in 1985, a fellowship in Clinical Neurophysiology at the Cleveland Clinic in 1988 and a fellowship in Clinical Epilepsy at the Yale School of Medicine in 1989.
Dr. Katz additionally holds numerous certifications in his field, including an Israeli Specialist’s Certificate in Neurology, which he earned in 1985 and American Board certification of Psychiatry and Neurology he earned in 1992. He was certified as a Diving Medical Officer in 1976 and a Medical Officer with the Israeli Academy of Military Medicine.
Since 2004, Dr. Katz has been in in solo practice with MedAhead, Inc., in Orange, Connecticut and has been the president of the company since 1995. From 1993 to 2013, Dr. Katz served as a consulting neurologist and assistant clinical professor of Neurology at Yale University School of Medicine and served as a partner in Neurology Associates of Norwalk PC, from 1993 to 2002. During that time, he also served as the medical Director of the Epilepsy Foundation of Connecticut and was the director of the Epilepsy Center, co-director of Diving Medicine and associate director of sleep medicine at Norwalk Hospital. Dr. Katz also previously served as the medical director of Telemedicine Consultants America, LLC .
In recognition of his accomplishments in his field, Dr. Katz has been the recipient of numerous awards and honors. He won the Merritt Putnam Fellowship of the American Foundation in Epilepsy in 1988, the William Gowers Epilepsy Fellowship of Abbott Pharmaceuticals in 1989 and the Hans Berger Epilepsy Fellowship of the American EEG Society in 1990. From 2002 to 2014, he was listed among the top doctors in the New York Metro Area with Castle Connolly, and in 2010 and 2013 was named Most Compassionate Doctor by Patients’ Choice. In 2008, 2010, and 2012, he won Best Doctor by Patients’ Choice, among a myriad of other accolades. In 2016 he established DK Electronics, LLC to promote an FDA approved medical device he invented, FlowKeepers®, that helps prevent deep vein thrombosis (DVT). Over the past few years Dr, Katz ran an IRB approved clinical trial examining the safety and efficacy of intrathecal immunoglobulin administration to patients with Alzheimer’s disease, a treatment that shows promise in a variety of neuroinflammatory conditions. In the coming years, he intends to experience continued growth and success with his medical device, his research and clinical trials.